Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-10-27

Clinical Trial Update: Fibrinogen for Treatment of Pediatric Dilutional Coagulopathy. FibPaed Study. [Phase 4]

View source ↗

Summary

Phase 4 FibPaed trial evaluating fibrinogen concentrate for treating pediatric dilutional coagulopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fibrinogen concentrate (Fibrinogen concentrate)

Snippet

Sponsor: University Children's Hospital, Zurich | Conditions: Blood Coagulation Disorders, Hemorrhage | Phase 4 | Status: COMPLETED